Rezolute, Inc. (RZLT) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2026, Rezolute reported revenue of $0. Net income was -$77.6M, or -$0.75 per diluted share. Operating activities generated -$64.6M of cash, leaving -$64.6M of free cash flow. At fiscal year end, Rezolute held $112.8M in total assets against $12.2M in total liabilities, including $10.6M of cash and equivalents.
Open the full interactive Rezolute financials → Quarterly statements, key ratios, valuation history and price charts.
Rezolute Key Stats
| Share Price | $4.61 |
|---|---|
| Market Cap | $479.0M |
| 52-Week Range | $1.40 – $10.94 |
| Shares Outstanding | 103.9 million (basic, 2026 Q4) |
Rezolute Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$22.9M | -$41.8M | -$56.0M | -$70.4M | -$79.9M | -$83.0M |
| Pre-Tax Income | -$20.9M | -$41.1M | -$51.8M | -$68.5M | -$74.4M | -$77.6M |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$20.9M | -$41.1M | -$51.8M | -$68.5M | -$74.4M | -$77.6M |
| Diluted EPS | -$2.72 | -$2.32 | -$1.01 | -$1.33 | -$0.98 | -$0.75 |
Rezolute Quarterly Results
| 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | -$18.1M | -$22.8M | -$16.2M | -$20.5M |
| Diluted EPS | -$0.18 | -$0.22 | -$0.16 | -$0.20 |
Rezolute Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $41.0M | $150.4M | $16.0M | $70.4M | $94.1M | $10.6M |
| Current Assets | $42.0M | $152.1M | $104.9M | $128.7M | $171.1M | $110.5M |
| Total Assets | $42.6M | $152.4M | $123.7M | $132.7M | $175.5M | $112.8M |
| Current Liabilities | $2.0M | $2.5M | $5.2M | $9.6M | $11.9M | $11.4M |
| Total Long-Term Debt | $14.0M | — | — | — | — | — |
| Total Liabilities | $16.5M | $2.9M | $7.5M | $11.7M | $13.4M | $12.2M |
| Shareholders' Equity | $26.1M | $149.5M | $116.2M | $121.0M | $162.1M | $100.7M |
Rezolute Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$20.4M | -$39.6M | -$44.5M | -$57.4M | -$69.1M | -$64.6M |
| Cash From Investing | $0 | — | -$101.5M | $48.7M | -$14.5M | -$21.1M |
| Cash From Financing | $51.5M | $149.0M | $11.6M | $63.0M | $107.3M | $2.2M |
| Free Cash Flow | — | -$39.6M | -$44.7M | -$57.4M | -$69.1M | -$64.6M |
Figures from Rezolute's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Rezolute financials page for every line item.
Rezolute Company Profile
| Ticker | RZLT |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Redwood City, California |
| Incorporated in | Nevada |
| Fiscal Year End | June 30 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001509261 |
Frequently Asked Questions
What was Rezolute's revenue in fiscal 2026?
Rezolute (RZLT) reported revenue of $0 for fiscal 2026.
What is Rezolute's annual revenue history?
Rezolute's annual revenue by fiscal year: 2021: $0; 2022: $0; 2023: $0; 2024: $0; 2025: $0; 2026: $0.
What was Rezolute's net income in fiscal 2026?
Rezolute reported net income of -$77.6M for fiscal 2026.
What was Rezolute's earnings per share (EPS) in fiscal 2026?
Rezolute's diluted EPS was -$0.75 for fiscal 2026 (adjusted for any later stock splits).
How much free cash flow did Rezolute generate in fiscal 2026?
Rezolute generated -$64.6M of free cash flow in fiscal 2026.
What was Rezolute's revenue last quarter?
In its most recent reported quarter (2026 Q4), Rezolute reported revenue of $0.
How many shares of Rezolute are outstanding?
Rezolute reported a weighted average of 103.9 million basic shares outstanding in 2026 Q4.
What is Rezolute's market cap?
Based on its latest closing price, Rezolute (RZLT) has a market capitalization of about $479.0M.
When does Rezolute's fiscal year end?
Rezolute's fiscal year end, as registered with the SEC, is June 30.
Where is Rezolute headquartered?
Rezolute lists its business address in Redwood City, California in its SEC filings.